Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lounis

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Antimicrobial Agents and Chemotherapy|May 27, 2005
Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosisSandeep Tyagi, E Nuermberger, T Yoshimatsu, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
Activities of roxithromycin against Mycobacterium avium infections in human macrophages and C57BL/6 miceL Struillou, Y Cohen, N Lounis, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in miceN Lounis, A Bentoucha, C Truffot-Pernot, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|January 22, 2008
[Growth follow-up of SGA children after 3 years of GH treatment]T Edouard, I Oliver, B Jouret, et al.
American Journal of Respiratory and Critical Care Medicine|May 12, 2000
Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimensN Daniel, N Lounis, B Ji, et al.
Hormone Research in Paediatrics|September 14, 2011
Endothelial function and mechanical arterial properties in children born small for gestational age: comparison with obese childrenB Jouret, Y Dulac, R Bassil Eter, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 22, 2021
Bedaquiline for multidrug-resistant TB in paediatric patientsR Moodliar, V Aksenova, M V G Frias, et al.
Antimicrobial Agents and Chemotherapy|March 7, 2012
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistanceA H Diacon, P R Donald, A Pym, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Antimicrobial Agents and Chemotherapy|May 27, 2005
Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosisSandeep Tyagi, E Nuermberger, T Yoshimatsu, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
Activities of roxithromycin against Mycobacterium avium infections in human macrophages and C57BL/6 miceL Struillou, Y Cohen, N Lounis, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in miceN Lounis, A Bentoucha, C Truffot-Pernot, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|January 22, 2008
[Growth follow-up of SGA children after 3 years of GH treatment]T Edouard, I Oliver, B Jouret, et al.
American Journal of Respiratory and Critical Care Medicine|May 12, 2000
Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimensN Daniel, N Lounis, B Ji, et al.
Hormone Research in Paediatrics|September 14, 2011
Endothelial function and mechanical arterial properties in children born small for gestational age: comparison with obese childrenB Jouret, Y Dulac, R Bassil Eter, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 22, 2021
Bedaquiline for multidrug-resistant TB in paediatric patientsR Moodliar, V Aksenova, M V G Frias, et al.
Antimicrobial Agents and Chemotherapy|March 7, 2012
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistanceA H Diacon, P R Donald, A Pym, et al.
Pageof 3